| 注册
首页|期刊导航|外科理论与实践|3-吲哚甲醇抗肿瘤作用的研究进展

3-吲哚甲醇抗肿瘤作用的研究进展

王贵民 樊昊 周乐其 温镕博 于冠宇 郝立强 张卫

外科理论与实践2026,Vol.31Issue(2):163-168,6.
✕
外科理论与实践2026,Vol.31Issue(2):163-168,6.DOI:10.16139/j.1007-9610.2026.02.11

3-吲哚甲醇抗肿瘤作用的研究进展

Progress in the anti-tumor effects of indole-3-carbinol

王贵民 1樊昊 1周乐其 1温镕博 1于冠宇 1郝立强 1张卫1

作者信息

  • 1. 海军军医大学附属长海医院肛肠外科,上海 200433
  • 折叠

摘要

Abstract

In recent years,indole-3-carbinol(I3C)has been introduced into tumor therapy research,playing a key role in inhibiting and interfering with the occurrence and development of various tumors.This article explored the mechanisms by which I3C and its indole-derived metabolite,3,3'-diindolylmethane(DIM),which is converted in the acidic environment of the stomach,serve as effective natural chemopreventive agents against multiple tumors.The physicochemical properties of I3C were presented alongside epidemiological studies,emphasizing its safety and efficacy.Furthermore,it provided a detail discussion of the molecular mechanisms of I3C's anti-tumor effects,including various signaling pathways such as the phosphoinositide 3-kinase/protein kinase B/mammalian target of rapamycin[PI3K/PKB(AKT)/mTOR]and aryl hydrocarbon receptor(AHR)pathways.This article served as a valuable reference for further research on I3C.

关键词

3-吲哚甲醇/磷脂酰肌醇3-激酶/蛋白激酶B通路/芳香烃受体/抗肿瘤

Key words

Indole-3-carbinol(I3C)/Phosphoinositide 3-kinase/protein kinase B[PI3K/PKB(AKT)pathway]/Aryl hydrocarbon receptor(AHR)/Anti-tumor

分类

医药卫生

引用本文复制引用

王贵民,樊昊,周乐其,温镕博,于冠宇,郝立强,张卫..3-吲哚甲醇抗肿瘤作用的研究进展[J].外科理论与实践,2026,31(2):163-168,6.

基金项目

国家自然科学基金(82072750) (82072750)

外科理论与实践

1007-9610

访问量0
|
下载量0
段落导航相关论文